Flexipak
Product Images NDC 69336-202

10 FDA label images from Sterling-knight Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Flexipak (NDC 69336-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sterling-knight Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Caps (Capsaicin Cream 60g)

Caps (Capsaicin Cream 60g)
Packaging label for Rugby Capsaicin Cream 0.025%, an external analgesic for penetrating pain relief. The label shows a 2.1 oz (60 g) tube size and includes drug facts such as active ingredient, uses, warnings, directions, inactive ingredients, and a barcode. Manufactured by Rugby Laboratories, Inc.*
FDA Label Image

Disod (Disod)

Disod (Disod)
Chemical structure diagram showing a molecule with a benzene ring containing two chlorine atoms and an amine group linked to another benzene ring with a sodium carboxylate substituent. This likely represents the active ingredient of the Flexipak product by Sterling-Knight Pharmaceuticals, LLC.*
FDA Label Image

Flexipak (Flexipak Box)

Flexipak (Flexipak Box)
Flexipak packaging label for a combination product containing Diclofenac Sodium 75mg delayed release tablets (60 count) and Capsaicin 0.025% cream (60g). The label features the brand name Flexipak prominently on a blue and white background, with the labeler Sterling-Knight Pharmaceuticals, LLC identified. It includes a warning to keep out of reach of children and storage instructions, along with the statement "Rx Only." The NDC 69336-202-01 is displayed on the packaging.*
FDA Label Image

Im1 (Im1)

Im1 (Im1)
Flexipak carton label from Sterling-Knight Pharmaceuticals, LLC. The label shows the product name Flexipak prominently in black and red text on a white background. No active ingredient, strength, dosage form, or package size details are visible on this image.*
FDA Label Image

Im2 (Im2)

Im2 (Im2)
The image shows a white rectangular pharmaceutical blister pack labeled with 'Flexipak' and the product NDC number 69336-202. The labeler listed is Sterling-Knight Pharmaceuticals, LLC. The blister pack contains multiple capsules arranged in rows, each capsule appearing to be beige or off-white in color with no visible imprint.*
FDA Label Image

Im3 (Im3)

Im3 (Im3)
Flexipak carton from Sterling-Knight Pharmaceuticals. The label has the brand name Flexipak prominently displayed in green and purple text. The packaging includes production codes, expiration date, and a barcode on the side panel. The panel is predominantly green with various printing details and regulatory markings.*
FDA Label Image

Tab1 (Tab1)

Tab1 (Tab1)
A text panel listing risk factors related to medication use and health conditions, including increasing doses and longer use of NSAIDs, smoking, drinking alcohol, older age, poor health, advanced liver disease, and bleeding problems.*
FDA Label Image

Tab2 (Tab2)

Tab2 (Tab2)
A text panel listing symptoms including shortness of breath, chest pain, weakness in one part or side of the body, slurred speech or trouble breathing, and swelling of the face or throat. The content appears to be a partial warning or side effect section from a medication guide or drug facts label.*
FDA Label Image

Tab3 (Tab3)

Tab3 (Tab3)
A text panel listing various side effects or symptoms potentially associated with a medication, including nausea, diarrhea, itching, jaundice, indigestion, flu-like symptoms, vomiting blood, blood or black tarry stool, unusual weight gain, skin rash or blisters with fever, and swelling of extremities.*
FDA Label Image

Table1 (Table1)

Table1 (Table1)
A data table titled 'Pharmacokinetic Parameters for Diclofenac' detailing mean values and coefficients of mean variation percentages for parameters in normal healthy adults aged 20 to 48 years. Parameters include bioavailability, Tmax (time to maximum concentration), oral clearance, renal clearance, apparent volume of distribution, and terminal half-life.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.